Pfizer Inc. (NYSE:PFE) has agreed to share a portion of the incremental net revenue it generates from higher drug prices overseas with the U.S. Department of Health and Human Services (HHS), according to newly released documents covering its Most Favored Nation (MFN) pricing agreement. The provision applies to medicines already on the market and runs […]Read More
Pfizer (PFE) Balances Global Pricing Opportunity with New Revenue Sharing
By Vardah Gill
